Estimaciones de analistas de Wall Street para Karyopharm Therapeutics Inc. (KPTI): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | -0.13 |
| EV / EBITDA | -1.15 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $154000 | $1.6M | $30.3M | $40.9M | $108.1M | $209.8M | $157.1M | $146.0M | $145.2M | $146.1M |
| Coste de Ventas | $86.9M | $107.3M | $161.4M | $2.4M | $2.7M | $3.4M | $5.2M | $4.9M | $6.0M | $5.9M |
| Beneficio Bruto | -$86.8M | -$105.7M | -$131.0M | $38.5M | $105.4M | $206.4M | $151.9M | $141.1M | $139.2M | $140.1M |
| I+D | $86.9M | $107.3M | $161.4M | $122.3M | $150.8M | $160.8M | $148.7M | $138.8M | $143.2M | $125.6M |
| Generales y Administrativos | $23.9M | $24.9M | $48.8M | $105.4M | $126.4M | $143.8M | $145.4M | $131.9M | $115.4M | $105.2M |
| Gastos Operativos | $110.9M | $132.1M | $210.2M | $227.8M | $277.2M | $304.7M | $294.1M | $270.6M | $258.7M | $230.8M |
| Beneficio Operativo | -$110.7M | -$130.5M | -$179.9M | -$189.3M | -$171.8M | -$98.3M | -$142.2M | -$129.5M | -$119.4M | -$90.7M |
| EBITDA | -$108.7M | -$128.2M | -$175.2M | -$182.9M | -$167.9M | -$97.0M | -$139.3M | -$118.4M | -$38.6M | -$149.9M |
| Gastos por Intereses | 0 | 0 | $2.5M | $15.6M | $27.1M | $26.0M | $25.0M | $23.8M | $37.4M | $45.8M |
| Beneficio Antes de Impuestos | -$109.4M | -$128.9M | -$178.4M | -$199.6M | -$196.0M | -$123.8M | -$164.9M | -$142.8M | -$76.4M | -$196.0M |
| Impuestos | $139000 | $63000 | $26000 | $40000 | $309000 | $268000 | $369000 | $323000 | $57000 | $43000 |
| Beneficio Neto | -$109.6M | -$129.0M | -$178.4M | -$199.6M | -$196.3M | -$124.1M | -$165.3M | -$143.1M | -$76.4M | -$196.0M |
| BPA | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| BPA Diluido | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| Acciones en Circulación (Diluidas) | $2.5M | $3.1M | $3.8M | $4.1M | $4.8M | $5.0M | $5.5M | $7.6M | $8.1M | $10.9M |
Precio
| Precio | $1.70 |
| Capitalización | $39M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALGS · BRNS · CVM · FGEN · INMB · MDCX · MRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de KPTI: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones